{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:41:48Z","timestamp":1788370908068,"version":"build-2803163510"},"reference-count":21,"publisher":"Japanese Society of Toxicology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2131\/jts.41.143","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T01:07:54Z","timestamp":1452647274000},"page":"143-146","source":"Crossref","is-referenced-by-count":20,"title":["Effect of penicillin-based antibiotics, amoxicillin, ampicillin, and piperacillin, on drug-metabolizing activities of human hepatic cytochromes P450"],"prefix":"10.2131","volume":"41","author":[{"given":"Toshiro","family":"Niwa","sequence":"first","affiliation":[{"name":"School of Pharmacy, Shujitsu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Morimoto","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shujitsu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Hirai","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shujitsu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Hata","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shujitsu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Hayashi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shujitsu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurie","family":"Imagawa","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shujitsu University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Fuhr, U., Anders, E.M., Mahr, G., S\u00f6rgel, F. and Staib, A.H. (1992): Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity <i>in vivo<\/i> and <i>in vitro<\/i>. Antimicrob. Agents Chemother., <b>36<\/b>, 942-948.","DOI":"10.1128\/AAC.36.5.942"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Funae, Y., Kishimoto, W., Cho, T., Niwa, T. and Hiroi, T. (2003): CYP2D in the brain. Drug Metab. Pharmacokinet., <b>18<\/b>, 337-349.","DOI":"10.2133\/dmpk.18.337"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Imaoka, S., Yamada, T., Hiroi, T., Hayashi, K., Sakaki, T., Yabusaki, Y. and Funae, Y. (1996): Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochem. Pharmacol., <b>51<\/b>, 1041-1050.","DOI":"10.1016\/0006-2952(96)00052-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Ito, K., Iwatsubo, T., Kanamitsu, S., Nakajima, Y. and Sugiyama, Y. (1998a): Quantitative prediction of<i> in vivo<\/i> drug clearance and drug interactions from <i>in vitro<\/i> data on metabolism, together with binding and transport. Annu. Rev. Pharmacol. Toxicol., <b>38<\/b>, 461-499.","DOI":"10.1146\/annurev.pharmtox.38.1.461"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Ito, K., Iwatsubo, T., Kanamitsu, S., Ueda, K., Suzuki, H. and Sugiyama, Y. (1998b): Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver. Pharmacol. Rev., <b>50<\/b>, 387-412.","DOI":"10.1016\/S0031-6997(24)01372-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Niwa, T., Hiroi, T., Tsuzuki, D., Yamamoto, S., Narimatsu, S., Fukuda, T., Azuma, J. and Funae, Y. (2004): Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6. Mol. Brain Res., <b>129<\/b>, 117-123.","DOI":"10.1016\/j.molbrainres.2004.06.030"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Niwa, T., Inoue, S., Shiraga, T. and Takagi, A. (2005): No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug. Biol. Pharm. Bull., <b>28<\/b>, 188-191.","DOI":"10.1248\/bpb.28.188"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Niwa, T., Murayama, N., Emoto, C. and Yamazaki, H. (2008): Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A5. Curr. Drug Metab., <b>9<\/b>, 20-33.","DOI":"10.2174\/138920008783331121"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Niwa, T., Murayama, N., Imagawa, Y. and Yamazaki, H. (2015): Regioselective hydroxylation of steroid hormones by human cytochromes P450. Drug Metab. Rev., <b>47<\/b>, 89-110.","DOI":"10.3109\/03602532.2015.1011658"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Niwa, T., Sato, R., Yabusaki, Y., Ishibashi, F. and Katagiri, M. (1999): Contribution of human hepatic cytochrome P450s and steroidogenic CYP17 to the N-demethylation of aminopyrine. Xenobiotica, <b>29<\/b>, 187-193.","DOI":"10.1080\/004982599238731"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Niwa, T., Shiraga, T., Hashimoto, T. and Kagayama, A. (2004): Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes. Biol. Pharm. Bull., <b>27<\/b>, 97-99.","DOI":"10.1248\/bpb.27.97"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Niwa, T., Yamamoto, S., Saito, M., Shiraga, T. and Takagi, A. (2007): Effect of cyclosporine and tacrolimus on cytochrome P450 activities in human liver microsomes. Yakugaku Zasshi, <b>127<\/b>, 209-216.","DOI":"10.1248\/yakushi.127.209"},{"key":"13","unstructured":"Pharmaceuticals and Medical Devices Agency. Methods of drug interaction studies (PMSB\/ELD Notification No. 813; June 4, 2001). http:\/\/www.nihs.go.jp\/phar\/pdf\/DiGlEngFinal011209.pdf."},{"key":"14","doi-asserted-by":"crossref","unstructured":"Rendic, S. (2002): Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab. Rev., <b>34<\/b>, 83-448.","DOI":"10.1081\/DMR-120001392"},{"key":"15","unstructured":"Sawacillin Package Insert, Astellas Pharma, January 2015, http:\/\/www.info.pmda.go.jp\/go\/pack\/6131001C1210_1_12\/"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Shimada, T., Yamazaki, H., Mimura, M., Inui, Y. and Guengerich, F.P. (1994): Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther., <b>270<\/b>, 414-423.","DOI":"10.1016\/S0022-3565(25)22379-5"},{"key":"17","unstructured":"Unasyn Package Insert, Pfizer Japan Inc., June 2015, http:\/\/www.info.pmda.go.jp\/downfiles\/ph\/PDF\/671450_6139504G1028_2_05.pdf"},{"key":"18","unstructured":"von Rosensteil, N.A. and Adam, D. (1995): Macrolide antibacterials. Drug interactions of clinical significance. Drug Saf., <b>13<\/b>, 105-122."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Williams, J.A., Hyland, R., Jones, B.C., Smith, D.A., Hurst, S., Goosen, T.C., Peterkin, V., Koup, J.R. and Ball, S.E. (2004): Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi\/AUC) ratios. Drug Metab. Dispos., <b>32<\/b>, 1201-1208.","DOI":"10.1124\/dmd.104.000794"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Wright, A.J. (1999): The penicillins. Mayo Clin. Proc., <b>74<\/b>, 290-307.","DOI":"10.4065\/74.3.290"},{"key":"21","unstructured":"Zosyn Package Insert, Taisho Toyama Pharmaceutical Co., Ltd., June 2015, http:\/\/www.info.pmda.go.jp\/go\/pack\/6139505F3020_1_07\/"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/41\/1\/41_143\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T03:36:29Z","timestamp":1748748989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/41\/1\/41_143\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.41.143","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}